Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors |
Baylor College of Medicine / Andras Heczey, MD |
R Accelerated Award Grants |
2023 |
Texas |
GENOME ORIGAMI: Refolding Aberrant Chromosome 3D Structure for Treating NUT Carcinoma |
Baylor College of Medicine / Kyle Eagen, PhD |
R Accelerated Award Grants |
2022 |
Texas |
Adoptive immunotherapy using clinical-grade T cells.
|
University of Texas M.D. Anderson Cancer Center / Laurence Cooper, MD, PhD |
Innovation Grants |
2007 |
Texas |
Parallel sequencing to identify the causes of childhood cancer
|
Baylor College of Medicine / Sharon Plon |
Innovation Grants |
2008 |
Texas |
Understanding factors contributing to retention in care among children with cancer in sub-Saharan Africa |
Baylor College of Medicine / Mark Zobeck, MD, PhD |
Psychosocial Launch Grant |
2019 |
Texas |
Strategies for Epigenetically Reprogramming Neuroblastoma Cancer Stem Cells |
Baylor College of Medicine / Jason Shohet, MD, PhD |
Innovation Grants |
2011 |
Texas |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |
Zebrafish Modeling of PAX3-FOXO1 Driven Rhabdomyosarcoma |
University of Texas Southwestern Medical Center / Genevieve Kendall, PhD |
Young Investigator Grants |
2015 |
Texas |
Role of H3.3-G34R mutation in pediatric high-grade glioma |
University of Texas M.D. Anderson Cancer Center / Jian Hu, PhD |
Innovation Grants |
2021 |
Texas |